• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物组与肿瘤的相互作用。

The Interaction Between the Microbiome and Tumors.

机构信息

State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, China.

Department of Cariology and Endodontics, West China School of Stomatology, Sichuan University, Chengdu, China.

出版信息

Front Cell Infect Microbiol. 2021 Aug 31;11:673724. doi: 10.3389/fcimb.2021.673724. eCollection 2021.

DOI:10.3389/fcimb.2021.673724
PMID:34532297
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8438519/
Abstract

Cancer is a significant global health problem and is characterized by a consistent increase in incidence and mortality rate. Deciphering the etiology and risk factors are essential parts of cancer research. Recently, the altered microbiome has been identified within the tumor microenvironment, tumor tissue, and even nonadjacent environments, which indicates a strong correlation between the microbiome and tumor development. However, the causation and mechanisms of this correlation remain unclear. Herein, we summarized and discussed the interaction between the microbiome and tumor progression. Firstly, the microbiome, which can be located in the tumor microenvironment, inside tumor tissues and in the nonadjacent environment, is different between cancer patients and healthy individuals. Secondly, the tumor can remodel microbial profiles by creating a more beneficial condition for the shifted microbiome. Third, the microbiome can promote tumorigenesis through a direct pathogenic process, including the establishment of an inflammatory environment and its effect on host immunity. The interactions between the microbiome and tumors can promote an understanding of the carcinogenesis and provide novel therapeutic strategies for cancers.

摘要

癌症是一个全球性的重大健康问题,其特征是发病率和死亡率持续上升。解析病因和风险因素是癌症研究的重要组成部分。最近,在肿瘤微环境、肿瘤组织甚至非相邻环境中都发现了微生物组的改变,这表明微生物组与肿瘤的发展之间存在很强的相关性。然而,这种相关性的因果关系和机制尚不清楚。在此,我们总结并讨论了微生物组与肿瘤进展之间的相互作用。首先,微生物组可以位于肿瘤微环境、肿瘤组织内和非相邻环境中,癌症患者和健康个体之间的微生物组存在差异。其次,肿瘤可以通过为移位的微生物组创造更有利的条件来重塑微生物图谱。第三,微生物组可以通过直接的致病过程促进肿瘤发生,包括建立炎症环境及其对宿主免疫的影响。微生物组与肿瘤之间的相互作用可以促进对致癌作用的理解,并为癌症提供新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/c334185fafae/fcimb-11-673724-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/db166d5e6e30/fcimb-11-673724-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/f36f51f4e1f6/fcimb-11-673724-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/c334185fafae/fcimb-11-673724-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/db166d5e6e30/fcimb-11-673724-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/f36f51f4e1f6/fcimb-11-673724-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9168/8438519/c334185fafae/fcimb-11-673724-g003.jpg

相似文献

1
The Interaction Between the Microbiome and Tumors.微生物组与肿瘤的相互作用。
Front Cell Infect Microbiol. 2021 Aug 31;11:673724. doi: 10.3389/fcimb.2021.673724. eCollection 2021.
2
Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.宿主微生物组的区室化:肿瘤微生物组如何塑造检查点免疫治疗的结果并提供治疗前景。
J Immunother Cancer. 2022 Nov;10(11). doi: 10.1136/jitc-2022-005401.
3
The impact of the human microbiome in tumorigenesis, cancer progression, and biotherapeutic development.人类微生物组在肿瘤发生、癌症进展和生物治疗开发中的影响。
BMC Microbiol. 2022 Feb 12;22(1):53. doi: 10.1186/s12866-022-02465-6.
4
Oral microbiome and its relationship with oral cancer.口腔微生物组及其与口腔癌的关系。
J Cancer Res Ther. 2024 Aug 1;20(4):1141-1149. doi: 10.4103/jcrt.jcrt_44_24. Epub 2024 Aug 29.
5
Concepts Collide: Genomic, Immune, and Microbial Influences on the Tumor Microenvironment and Response to Cancer Therapy.概念碰撞:基因组、免疫和微生物对肿瘤微环境和癌症治疗反应的影响。
Front Immunol. 2018 May 4;9:946. doi: 10.3389/fimmu.2018.00946. eCollection 2018.
6
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response.超越肠道:肿瘤内微生物组对肿瘤发生和治疗反应的影响。
Cancer Commun (Lond). 2024 Oct;44(10):1130-1167. doi: 10.1002/cac2.12597. Epub 2024 Aug 1.
7
The Gut Microbiome and Pancreatic Cancer Development and Treatment.肠道微生物组与胰腺癌的发生发展和治疗。
Cancer J. 2023;29(2):49-56. doi: 10.1097/PPO.0000000000000647.
8
Microbiome Conundrum in Colon Cancer: Development, Progression, and Therapeutics.肠道微生物组在结直肠癌中的难题:发展、进展和治疗。
Crit Rev Oncog. 2020;25(2):129-139. doi: 10.1615/CritRevOncog.2020035135.
9
Role of Microbiome in Carcinogenesis Process and Epigenetic Regulation of Colorectal Cancer.微生物群落在结直肠癌发生过程中的作用及表观遗传调控
Methods Mol Biol. 2018;1856:35-55. doi: 10.1007/978-1-4939-8751-1_3.
10
Host-Microbiome Interaction in Lung Cancer.肺癌中的宿主-微生物组相互作用。
Front Immunol. 2021 May 24;12:679829. doi: 10.3389/fimmu.2021.679829. eCollection 2021.

引用本文的文献

1
Unravelling novel microbial players in the breast tissue of TNBC patients: a meta-analytic perspective.解析三阴性乳腺癌患者乳腺组织中的新型微生物参与者:荟萃分析视角
NPJ Biofilms Microbiomes. 2025 Sep 9;11(1):182. doi: 10.1038/s41522-025-00816-5.
2
Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine-A Systematic Review.癌症免疫治疗中肠道微生物群的应用:机制、挑战及个性化医疗途径——一项系统综述
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251365700. doi: 10.1177/15330338251365700. Epub 2025 Aug 28.
3
Chlamydia muridarum Causes Persistent Subclinical Infection and Elicits Innate and Adaptive Immune Responses in C57BL/6J, BALB/cJ, and J:ARC(S) Mice Following Exposure to Shedding Mice.

本文引用的文献

1
Diet, Microbiome, and Cancer Immunotherapy-A Comprehensive Review.饮食、微生物组与癌症免疫治疗:全面综述
Nutrients. 2021 Jun 28;13(7):2217. doi: 10.3390/nu13072217.
2
The Comprehensive "Omics" Approach from Metabolomics to Advanced Omics for Development of Immune Checkpoint Inhibitors: Potential Strategies for Next Generation of Cancer Immunotherapy.从代谢组学到高级组学的全面“组学”方法在免疫检查点抑制剂开发中的应用:下一代癌症免疫疗法的潜在策略。
Int J Mol Sci. 2021 Jun 28;22(13):6932. doi: 10.3390/ijms22136932.
3
The Evolution of Cancer Immunotherapy.
鼠衣原体在接触排菌小鼠后,可在C57BL/6J、BALB/cJ和J:ARC(S)小鼠中引起持续性亚临床感染并引发先天性和适应性免疫反应。
Comp Med. 2024 Dec 1;74(6):373-391. doi: 10.30802/AALAS-CM-24-057.
4
Ferrocenyl-Substituted Curcumin Derivatives as Potential SHP-2 Inhibitors for Anticolorectal Cancer: Design, Synthesis and Evaluation.二茂铁基取代的姜黄素衍生物作为潜在的抗结直肠癌SHP-2抑制剂:设计、合成与评价
ACS Omega. 2024 Dec 18;9(52):51701-51718. doi: 10.1021/acsomega.4c10629. eCollection 2024 Dec 31.
5
Recent Developments in Glioblastoma-On-A-Chip for Advanced Drug Screening Applications.用于先进药物筛选应用的胶质母细胞瘤芯片的最新进展
Small. 2025 Jan;21(1):e2405511. doi: 10.1002/smll.202405511. Epub 2024 Nov 13.
6
Causes Persistent Subclinical Infection and Elicits Innate and Adaptive Immune Responses in C57BL/6J, BALB/cJ and J:ARC(S) Mice Following Exposure to Shedding Mice.在接触排毒小鼠后,可导致C57BL/6J、BALB/cJ和J:ARC(S)小鼠出现持续性亚临床感染并引发先天性和适应性免疫反应。
bioRxiv. 2024 Sep 6:2024.07.16.603732. doi: 10.1101/2024.07.16.603732.
7
The oral microbiome: diversity, biogeography and human health.口腔微生物组:多样性、生物地理学与人类健康。
Nat Rev Microbiol. 2024 Feb;22(2):89-104. doi: 10.1038/s41579-023-00963-6. Epub 2023 Sep 12.
8
Effects of chemotherapy and immunotherapy on microbial diversity in TME and engineered bacterial-mediated tumor therapy.化疗和免疫疗法对 TME 中微生物多样性的影响以及工程菌介导的肿瘤治疗。
Front Immunol. 2023 Feb 2;14:1084926. doi: 10.3389/fimmu.2023.1084926. eCollection 2023.
9
Predictive biomarkers of colon cancer immunotherapy: Present and future.结肠癌免疫治疗的预测生物标志物:现状与未来。
Front Immunol. 2022 Nov 22;13:1032314. doi: 10.3389/fimmu.2022.1032314. eCollection 2022.
10
The FnBPA from methicillin-resistant promoted development of oral squamous cell carcinoma.耐甲氧西林金黄色葡萄球菌的纤维黏连蛋白结合蛋白A促进口腔鳞状细胞癌的发展。
J Oral Microbiol. 2022 Jul 15;14(1):2098644. doi: 10.1080/20002297.2022.2098644. eCollection 2022.
癌症免疫疗法的演变
Vaccines (Basel). 2021 Jun 8;9(6):614. doi: 10.3390/vaccines9060614.
4
Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer.肠道微生物组和微生物衍生代谢物在癌症免疫检查点阻断免疫治疗中的作用。
Genome Med. 2021 Jun 23;13(1):107. doi: 10.1186/s13073-021-00923-w.
5
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.肿瘤微环境中与免疫抵抗和耐药性相关的方面。
Front Immunol. 2021 May 27;12:656364. doi: 10.3389/fimmu.2021.656364. eCollection 2021.
6
The role of microbiome in colorectal carcinogenesis and its clinical potential as a target for cancer treatment.微生物群落在结直肠癌发生中的作用及其作为癌症治疗靶点的临床潜力。
Intest Res. 2022 Jan;20(1):31-42. doi: 10.5217/ir.2021.00034. Epub 2021 May 21.
7
Promotes Colorectal Carcinoma by Activating the Hematopoietic Inflammasome.促进结直肠癌发生的造血炎症小体。
Cancer Res. 2021 May 15;81(10):2745-2759. doi: 10.1158/0008-5472.CAN-20-3827. Epub 2021 Mar 18.
8
Crossing Kingdoms: How the Mycobiota and Fungal-Bacterial Interactions Impact Host Health and Disease.跨界王国:菌相与真菌-细菌相互作用如何影响宿主健康与疾病
Infect Immun. 2021 Mar 17;89(4). doi: 10.1128/IAI.00648-20.
9
The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants.癌症微生物组图谱:一种泛癌症比较分析,用于区分组织驻留微生物群与污染物。
Cell Host Microbe. 2021 Feb 10;29(2):281-298.e5. doi: 10.1016/j.chom.2020.12.001. Epub 2021 Jan 6.
10
The Intestinal Microbiota and Colorectal Cancer.肠道微生物群与结直肠癌。
Front Immunol. 2020 Nov 30;11:615056. doi: 10.3389/fimmu.2020.615056. eCollection 2020.